Home
About
FAQ
History (1)
Re: TP53INP1 as new therapeutic target in castration-resistant prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Re: TP53INP1 as new therapeutic target in castration-resistant prostate cancer.
Atala A. Re: TP53INP1 as new therapeutic target in castration-resistant prostate cancer. J Urol. 2013 May; 189(5):1990-1.
View in:
PubMed
authors with profiles
Anthony Atala MD